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Acrolein is a pathogenic mediator of alcoholic liver disease;
alcohol-induced acrolein accumulation triggers endoplasmic
reticulum stress without endoplasmic reticulum adaptive/
protective responses, leading to apoptosis and liver injury.
Acrolein removal by scavengers (hydralazine) prevents
alcohol-induced liver injury in mice, and shows therapeutic
potential in alcoholic liver disease.
BACKGROUND & AIMS: Alcoholic liver disease (ALD) remains
a major cause of morbidity and mortality, with no Food and
Drug Administration–approved therapy. Chronic alcohol con-
sumption causes a pro-oxidant environment and increases he-
patic lipid peroxidation, with acrolein being the most reactive/
toxic by-product. This study investigated the pathogenic role
of acrolein in hepatic endoplasmic reticulum (ER) stress, stea-
tosis, and injury in experimental ALD, and tested acrolein
elimination/scavenging (using hydralazine) as a potential
therapy in ALD.
METHODS: In vitro (rat hepatoma H4IIEC cells) and in vivo
(chronicþbinge alcohol feeding in C57Bl/6 mice) models were
used to examine alcohol-induced acrolein accumulation and
consequent hepatic ER stress, apoptosis, and injury. In addition,
the potential protective effects of the acrolein scavenger,
hydralazine, were examined both in vitro and in vivo.
RESULTS: Alcohol consumption/metabolism resulted in
hepatic accumulation of acrolein-protein adducts, by up-
regulation of cytochrome P4502E1 and alcohol dehydroge-
nase, and down-regulation of glutathione-s-transferase-P,
which metabolizes/detoxiﬁes acrolein. Alcohol-induced acro-
lein adduct accumulation led to hepatic ER stress, proapoptotic
signaling, steatosis, apoptosis, and liver injury; however, ER-
protective/adaptive responses were not induced. Notably,
direct exposure to acrolein in vitro mimicked the in vivo effects
of alcohol, indicating that acrolein mediates the adverse effects
of alcohol. Importantly, hydralazine, a known acrolein scav-
enger, protected against alcohol-induced ER stress and liver
injury, both in vitro and in mice.
CONCLUSIONS: Our study shows the following: (1) alcohol
consumption triggers pathologic ER stress without ER adapta-
tion/protection; (2) alcohol-induced acrolein is a potential
therapeutic target and pathogenic mediator of hepatic ER
stress, cell death, and injury; and (3) removal/clearance
of acrolein by scavengers may have therapeutic potential inALD. (Cell Mol Gastroenterol Hepatol 2016;2:685–700; http://
dx.doi.org/10.1016/j.jcmgh.2016.05.010)
Keywords: Lipid Peroxidation; Apoptosis; Therapeutic; CHOP.
lcohol consumption can lead to alcoholic liver dis-Aease (ALD), which remains a major cause of
morbidity and mortality worldwide and in the United States.
Despite the profound economic and health impact, there is
no Food and Drug Administration–approved therapy for any
stage of ALD,1 emphasizing the need for research into
therapeutic interventions during the early initiating stages
of the disease. Furthermore, only approximately 20% of
heavy alcohol drinkers develop liver disease, and diet and
environment are considered potential determining factors.
The pathogenesis of ALD is multifactorial, and although
oxidative stress, lipid peroxidation, and endoplasmic retic-
ulum (ER) stress are known etiologic factors,2 the molecular
mediators of hepatic injury remain poorly deﬁned.
Hepatic ER stress and the unfolded protein response
(UPR) are thought to play a critical role in the pathogenesis
of ALD.3 ER stress is mediated primarily by the ER protein
BiP/glucose-regulated protein (GRP)78 via 3 ER sensors:
activating transcription factor (ATF)6, inositol-requiring
enzyme 1 (IRE1), and protein kinase RNA-like endo-
plasmic reticulum kinase (PERK). ER stress comprises both
pathologic and adaptive responses; UPR adaptive responses
reduce the protein burden by decreased synthesis and
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inducing ER chaperones to enhance folding capacity. If the
adaptive/protective reactions are inadequate or if the ER
stress is prolonged or extreme, apoptotic cell death ensues
via pathways involving activation of cJun N-terminal kinase
(JNK) and caspases, and up-regulation of proapoptotic
proteins such as CCAAT/enhancer-binding protein homol-
ogous protein (CHOP), growth arrest DNA damage (GADD)
153 and GADD 34.4 Alcohol consumption is known to cause
hepatic ER stress along with steatosis, inﬂammation, and
apoptosis, and reducing ER stress decreases alcoholic liver
injury.5,6 Although oxidative stress is known to contribute to
ER stress,7 the exact cause and pathogenic mediators of
alcohol-induced ER stress in ALD remain unclear.
Alcohol consumption and metabolism via alcohol dehy-
drogenase (ADH), cytochrome P4502E1 (CYP2E1), and
catalase pathways generates free radicals, leading to
increased lipid peroxidation (LPO) of polyunsaturated fatty
acids (PUFAs).6–8 The dietary consumption of PUFAs,
particularly linoleic acid, has increased dramatically in the
past 2 decades, thereby increasing the substrate availability
for LPO. LPO gives rise to a, b-unsaturated aldehydes, such
as 4-hydroxynonenal, malondialdehyde, and acrolein. Acro-
lein is the most reactive and toxic electrophile produced by
LPO9,10; moreover, it is found at approximately 40 times
greater concentration and has a signiﬁcantly longer half-life
than other reactive oxidative species (days as compared
with less than a second).11,12 Acrolein is metabolized and
cleared primarily by conjugation to glutathione catalyzed by
glutathione-s-transferase-Pi (GSTP). If not removed, acrolein
can form covalent protein adducts, generally leading to
impaired protein structure and function. Accumulation of
such adducted/misfolded proteins can trigger ER stress, and
acrolein-induced ER stress is shown in vitro in various cell
types.13 Increased acrolein adduct levels are linked patho-
logically with several diseases that are associated with
oxidative stress, including cancer,14 Alzheimer’s,15 Sjogren’s
syndrome autoimmune disorder,16 and cerebral stroke/
infarction.17 However, the role of acrolein in ALD has not
been investigated. In this study, we investigated the patho-
logic contribution of acrolein in alcohol-induced hepatic ER
stress, steatosis, and liver injury, and we tested, both in vitro
and in vivo, whether removal of acrolein by using scaven-
gers is effective in preventing liver injury in ALD.
Materials and Methods
Reagents
General chemicals, hydralazine, carnosine, acrolein, and
b-actin antibody were purchased from Sigma Aldrich (St.
Louis, MO). Acrolein Nε-(3-formyl-3,4-dehydropiperidino)
lysine (FDP-lysine) antibodies were purchased from Abcam
(Cambridge, MA). All other antibodies were purchased from
Cell Signaling (Beverly, MA). Cell culture supplies were
obtained from Invitrogen (Carlsbad, CA).
Cell Culture
H4IIEC, a rat hepatoma cell line, was obtained from
American Type Culture Collection (Rockville, MD) and usedaccording to the manufacturer’s instructions. All treatments
were performed on subconﬂuent monolayers of cells.18 Each
experiment was replicated independently at least 3 times.
Animal Studies
We used an established model of ALD (National Institute
on Alcohol Abuse and Alcoholism [NIAAA] model19). Male
C57BL/6J mice (12 weeks of age) were obtained from
Jackson Laboratories (Bar Harbor, ME), and maintained at
25C with a 12:12-hour light/dark cycle. The mice were fed
(ad libitum) a Lieber–DeCarli liquid diet (corn oil/LA
enriched; Research Diet, New Brunswick, NJ.) containing 5%
ethanol (wt/vol or 35% of calories) or an isocaloric maltose
dextrin Lieber–DeCarli liquid diet as (pair-fed) control for
10 days. This was followed by a single oral gavage of ethanol
(5 g/kg body weight, or maltose dextrin as control) on day
11. Blood and liver samples were collected 9 hours later.
Hydralazine (5 mg/kg body weight) was administered by
daily intraperitoneal injection along with alcohol feeding.
We used 6 mice in each group based on our earlier obser-
vations and published literature in this mouse model. All
experimental protocols were conducted under a protocol
approved by the University of Louisville Institutional Animal
Care and Use Committee in accordance with the National
Institutes of Health Ofﬁce of Laboratory Animal Welfare
Guidelines (available: http://grants.nih.gov/grants/olaw/
olaw.htm).
Acrolein Adducts Assay
Cryostat mouse liver sections (5 mmol/L) and H4IIEC
cells grown on coverslips were ﬁxed, stained using poly-
clonal rabbit antibodies speciﬁc for acrolein FDP-lysine
adducts, and examined by light microscopy. Quantiﬁcation
was performed using ImageJ Microscopy Image Analysis
Software (National Institutes of Health, Bethesda, MD) by
calculating the average intensity of the ﬁeld-of-view from
microscope ﬁelds (at least 4 images per sample from cells
and 10 images/mouse from each group).
Small Interfering RNA Transfection
Before alcohol or acrolein treatment, small interfering
RNAs (siRNAs) speciﬁc for rat GSTP or scrambled RNA
(Thermo Fisher, Grand Island, NY) as a negative control
were transfected into H4IIEC cells with Lipofectamine
RNAiMAX Transfection Reagent (Thermo Fisher Scientiﬁc)
according to the manufacturer’s instructions. The ﬁnal
concentration of each transfected RNA was 25 nmol/L.
Inhibition of GSTP was conﬁrmed by examining GSTP
messenger RNA (mRNA) and protein levels. Cells were
treated 72 hours after transfection with alcohol or acrolein
for 24 hours.
Cell Viability–3, (4, 5-Dimethylthiazol-2-Yl) 2,
5-Diphenyltetrazolium Bromide Assay
Cell survival/cell death was measured in treated cells by
the 3, (4, 5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium
bromide assay as described.18
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Equivalent proteins of total liver or cell extracts were
analyzed by standard Western blot using speciﬁc commer-
cial antibodies. Proteins were visualized using enhanced
chemiluminescence (GE Healthcare, Piscataway, NJ) and
quantiﬁed by densitometry using Imagelab software (Her-
cules, CA). Blots were reprobed with antibody to b-actin to
ensure equivalent loading. The density ratio of each band
compared with its corresponding b-actin band was deter-
mined and normalized to the control value, which was set to
1. Numbers in the ﬁgures represent the density ratio or the
group mean for each group of mice.
RNA Isolation and Real-Time Quantitative
Polymerase Chain Reaction Analysis
Total RNA was isolated using TRIzol (Invitrogen) and
subjected to real-time quantitative polymerase chain reac-
tion using SYBR green I dye reagents and speciﬁc primers
(Primer-BLAST; National Center for Biotechnology Infor-
mation, National Institutes of Health) with an ABI prism
7500 system (Applied Biosystems, Foster City, CA). A
dissociation curve analysis was performed to conﬁrm
primer speciﬁcity, and relative mRNA expression was
calculated using the Delta-Delta-Ct method from duplicate
samples after normalization to b-actin.
Liver Histology and Steatosis
Liver sections were stained with H&E or Oil Red O, and
examined by light microscopy.20
Liver Cell Apoptosis
Liver cell apoptosis was assessed by terminal deoxy-
nucleotidyl transferase–mediated deoxyuridine triphos-
phate nick-end labeling (TUNEL) assay using the ApopTag
Peroxidase in Situ Apoptosis Detection kit (Chemicon,
Temecula, CA). Quantiﬁcation of apoptosis was performed
by counting the positively stained cells in 10 ﬁelds from
each mouse liver.
Liver Injury
Serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) levels were measured using Enzy-
matic Assay Kits (Thermo Scientiﬁc, Waltham, MA).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
version 5.01 for Windows (GraphPad Software, Inc, La Jolla,
CA). Data were analyzed, as appropriate, by the Student t
test (for analysis of 2 groups) or by unpaired analysis of
variance with Bonferroni post-test analysis (for >2 groups),
with data from at least 3 experiments or 6 mice per group.
Differences were considered statistically signiﬁcant for a P
value less than .05.
Results
In this study, we examined the contributory role of the
lipid-derived aldehyde, acrolein, to alcohol-induced liverinjury using cultured rodent hepatoma cells (H4IIEC), and
the chronicþbinge murine model of ALD (also called the
NIAAA model). This is a well-accepted mouse model for
hepatic steatosis and hepatocellular injury in ALD, and re-
ﬂects a common drinking pattern in human beings, partic-
ularly in patients with ALD who often are both chronic and
binge drinkers.19,21Alcohol Consumption Leads to Hepatic
Acrolein Generation and Accumulation of
Acrolein Adducts
To investigate the theory that acrolein is a pathogenic
mediator of alcoholic liver disease, we ﬁrst examined
whether alcohol consumption led to acrolein build-up in the
liver. Although free acrolein is extremely labile and difﬁcult
to quantify, it readily reacts with cellular proteins to form
covalent adducts that then can be assessed. Acrolein can
form Michael addition-type adducts with cysteines, histi-
dines, and lysines of proteins; the acrolein-lysine adduct,
FDP-lysine, is readily detectable using speciﬁc antibodies. A
marked increase was observed in the levels of acrolein–-
protein adducts (brown staining of acrolein–FDP-lysine
adducts) in the livers of alcohol-fed mice (Figure 1A)
compared with controls, showing that alcohol consumption
led to the hepatic generation of acrolein. The alcohol-
induced acrolein adduct accumulation was not largely
zone-speciﬁc, but was increased slightly close to the portal
vein in some animals; in addition, both cytoplasmic and
nuclear accumulation was seen. Quantiﬁcation of acrolein
adducts showed a 3-fold, statistically signiﬁcant difference
between control and alcohol-fed livers (Figure 1B).
To determine the mechanisms underlying alcohol-
induced acrolein accumulation, we examined enzymes that
primarily metabolize alcohol, namely, ADH and CYP2E1.
Alcohol is known to up-regulate CYP2E1 and increase its
own metabolism, thereby leading to oxidative stress and
enhanced LPO. Hence, it is likely to generate higher levels of
the LPO-derived aldehydes, such as acrolein. Accordingly,
we examined CYP2E1 and ADH expression in the livers of
control vs alcohol-fed mice. As anticipated, alcohol feeding
led to a robust increase in CYP2E1 protein levels in the
alcohol-fed mice (Figure 1C). However, CYP2E1 mRNA was
decreased by alcohol feeding (Figure 1D). Similar effects
were seen in hepatic ADH, wherein ADH mRNA was
decreased (Figure 1D) and ADH protein levels were
increased slightly by alcohol (Figure 1C). An alcohol-induced
increase in CYP2E1 protein in the absence of transcriptional
up-regulation of the mRNA has been proposed to be caused
by stabilization of the protein22; whether the same occurs
with ADH remains to be investigated. The concentration of
acrolein in the liver is modulated not only by its generation,
but also by the rate of detoxiﬁcation or removal. Because
acrolein is metabolized and cleared primarily via conjuga-
tion with glutathione catalyzed by the enzyme GSTP,23 we
also examined the effects of alcohol on hepatic GSTP levels.
Alcohol consumption resulted in a decrease in the hepatic
levels of both GSTP mRNA (Figure 1D) and GSTP protein
(Figure 1C) as seen in alcohol-fed mice compared with
Figure 1. Alcohol consumption leads to accumulation of acrolein-protein adducts, up-regulation of ADH and CYP2E1,
and down-regulation of GSTP in mice livers. (A) Accumulation of acrolein adducts in mice livers by immunohistochemistry
using speciﬁc FDP-lysine antibodies (magniﬁcation, 20 and 80). (B) Quantiﬁcation of acrolein adducts observed in panel A.
Means ± SEM, n ¼ 6 mice. ***P < .001 compared with control by analysis of variance–Bonferroni analysis. (C) ADH, CYP2E1,
and GSTP protein levels in mice livers. Numbers represent mean densitometry ratios normalized to corresponding b-actin
levels. (D) ADH, CYP2E1, and GSTP mRNA levels. Means ± SEM, n ¼ 6 mice. ***P < .001 compared with control by analysis of
variance–Bonferroni analysis. C, control; E, alcohol.
688 Chen et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 5control, suggesting that the decrease in GSTP may
contribute to acrolein accumulation in the livers of alcohol-
fed mice.
By using cultured rodent hepatic cells that are known to
metabolize alcohol (H4IIEC cells), we assessed whether
in vitro exposure to alcohol resulted in the accumulation of
acrolein adducts, similar to that seen in livers of alcohol-fed
mice. Considerable acrolein adduct accumulation was seen
in H4IIEC cells that were treated for 24 hours with alcohol
(200 mmol/L) compared with untreated cells (Figure 2A).
Alcohol is metabolized in the liver by ADH or CYP2E1 into
its primary metabolite, acetaldehyde, which causes
increased reactive oxygen species production, leading to
enhanced LPO. Based on the acrolein build-up seen in
alcohol-exposed mice and cultured cells, we explored the
direct role of the alcohol metabolite, acetaldehyde, in acro-
lein generation and adduct accumulation in hepatocytes.
Cells were exposed in vitro to acetaldehyde (50 or 100
mmol/L) for 24 hours, and acrolein adduct levels were
examined. Similar to alcohol, direct exposure of cells to
acetaldehyde resulted in signiﬁcant acrolein adduct accu-
mulation (Figure 2A). Quantiﬁcation showed that treatment
with alcohol and 100 mmol/L acetaldehyde caused a sta-
tistically signiﬁcant increase in acrolein adducts, and asimilar trend (but not signiﬁcant) was seen with the lower
concentration of acetaldehyde (Figure 2A). Once formed,
acetaldehyde is metabolized further by aldehyde dehydro-
genase (ALDH) enzymes, particularly ALDH2, which also is
known to metabolize and remove reactive unsaturated
aldehydes such as acrolein. Hence, we tested whether
(N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide), a
known agonist of ALDH2, affected alcohol-induced acrolein
build-up. Pretreatment of cells with (N-(1,3-Benzodioxol-5-
ylmethyl)-2,6-dichlorobenzamide) before alcohol exposure
considerably decreased the accumulation of acrolein ad-
ducts (Figure 2B and C), showing that stimulating ALDH2
attenuated alcohol-induced acrolein accumulation. Further-
more, to determine whether acrolein build-up was depen-
dent on alcohol metabolism, H4IIEC cells also were exposed
to various known inhibitors of alcohol metabolism before
alcohol exposure. Treatment of cells with either pyrazole or
4-methylpyrazole (which suppress both ADH and CYP2E1-
dependent alcohol metabolism24), substantially attenuated
the accumulation of alcohol-induced acrolein adducts
(Figure 2B and C). In comparison, allyl sulﬁde, which is a
more selective CYP2E1 inhibitor, was less effective in
blocking alcohol-induced acrolein build-up, suggesting that
both ADH and CYP2E1 pathways led to acrolein generation,
Figure 2. Effect of pharmacologic modulators of alcohol metabolism on alcohol-induced acrolein adduct accumulation
in cultured hepatic cells. (A) Accumulation (magniﬁcation, 20) and quantiﬁcation of acrolein adducts by immunocyto-
chemistry using speciﬁc FDP-lysine antibodies in H4IIEC cells treated for 24 hours as follows: untreated control cells (C) or
cells treated with 200 mmol/L alcohol (E), 50 mmol/L acetaldehyde (AA50) or 100 mmol/L acetaldehyde (AA100). Means ± SEM
(n ¼ 4). **P < .01 and ***P < .001 compared with control by analysis of variance–Bonferroni analysis. (B) Accumulation of
acrolein adducts (magniﬁcation, 20) in H4IIEC cells treated for 24 hours as follows: untreated control cells (C), cells treated
with 200 mmol/L alcohol alone (E), or 200 mmol/L alcohol in the presence of 10 mmol/L (N-(1,3-Benzodioxol-5-ylmethyl)-2,6-
dichlorobenzamide) ((N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide)þE), 10 mmol/L 4-methyl pyrazole (4MPþE), 10
mmol/L Pyrazole (PYRþE), or 10 mmol/L allyl sulﬁde (ASþE). (C) Quantiﬁcation of acrolein adducts in panel B. Means ± SEM
(n ¼ 4). **P < .01 and ***P < .001 compared with control by analysis of variance–Bonferroni analysis. (D) Inhibition of GSTP
mRNA and protein by siRNA transfection in H4IIEC cells. For polymerase chain reaction analysis: means ± SEM by analysis of
variance–Bonferroni analysis. *P < .05 and **P < .01 compared with control. For Western blot: numbers represent mean
densitometry ratios normalized to b-actin. (E) Accumulation of acrolein adducts (magniﬁcation, 20) in transfected H4IIEC
cells. (F) Quantiﬁcation of acrolein adducts in panel E. Means ± SEM, n ¼ 4. *P < .05 and ***P < .001 compared with control by
analysis of variance–Bonferroni analysis. C, control; E, 200 mmol/L alcohol; A, 20 mmol/L acrolein; nt, not transfected; si, GSTP
siRNA; and sc, scrambled RNA.
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insufﬁcient to eliminate acrolein adduct accumulation
(Figure 2B and C). To further investigate the role of down-
regulation of GSTP in the alcohol-induced build-up of
acrolein adducts, we used siRNA in H4IIEC cells to effec-
tively inhibit GSTP mRNA and protein (Figure 2D). Genetic
inhibition of GSTP by siRNA led to an increase in the accu-
mulation of acrolein adducts (Figure 2E and F) after treat-
ment with alcohol or acrolein, which was not seen in
untransfected cells or those transfected with scrambled
RNA. These data conﬁrmed that the down-regulation of
GSTP by alcohol may be a novel mechanism that contributes
to enhanced alcohol-induced hepatic acrolein generation
and adduct accumulation. Thus, our data show that alcohol
consumption and metabolism causes acrolein accumulationby simultaneously up-regulating enzymes that lead to
acrolein generation and down-regulating the enzyme that
metabolizes and removes acrolein.Alcohol-Induced Hepatic Acrolein Adduct
Accumulation Is Associated With ER Stress,
With Minimal Activation of ER Adaptive/
Protective Responses
The alcohol-induced accumulation of acrolein-adducted
proteins in the liver is likely to increase the burden on the
cellular ER protein folding machinery, which if over-
whelmed can trigger ER stress. Indeed, in our study, alcohol
feeding and the resultant acrolein adduct accumulation was
associated with up-regulation of the prototypical ER stress
Figure 2. (continued).
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the mRNA (Figure 3A) and protein levels (Figure 3B). The
increase in ATF3 and ATF4 was attributed to phospho-
activation of the upstream signaling proteins, PERK and
eukaryotic translation initiation factor 2a (Figure 3C).
Furthermore, the effect of alcohol on the adaptation/
protective responses associated with ER stress also was
studied by examining the gene expression of hallmark ER
chaperones, GRP78 and GRP94. These chaperones can
promote protein folding, and thereby relieve ER stress and
provide protection. A small (but statistically signiﬁcant)
increase was seen in the mRNAs of both GRP78 and GRP94(Figure 4A), whereas at the protein level, only GRP78 was
increased marginally (Figure 4B) in alcohol-fed mice, sug-
gesting that cellular ER-adaptive responses were not acti-
vated robustly. Next, to determine the underlying cause, we
examined the transcription factors that are thought to
regulate chaperone gene expression, namely, ATF6 and
X-box binding protein-1 (XBP1). Activation of ATF6 by
proteolytic cleavage from the inactive approximately
90-kilodalton fragment into the active approximately
50-kilodalton cleaved form (Figure 4C) was seen in alcohol-
fed mice, showing that the ATF6-mediated ER stress
pathway also was triggered in this model of alcohol
Figure 3. Alcohol-induced accumulation of acrolein ad-
ducts causes hepatic ER stress in mice livers. (A) ATF3
and ATF4 mRNA levels. Means ± SEM, n ¼ 6 mice. **P < .01
compared with control by the Student t test. (B) ATF3 and
ATF4 protein levels. (C) Phospho-PERK and phospho-
eukaryotic translation initiation factor 2 a (eIF2a) protein
levels. (B and C) Numbers represent mean densitometry ra-
tios normalized to corresponding control proteins (b-actin,
total PERK, or eIF2a). C, control; E, alcohol.
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splicing of XBP1 mRNA owing to ER stress-induced activa-
tion of IRE1 endonuclease activity via oligomerization, and
subsequent autophosphorylation. Accordingly, we examined
IRE1 phosphorylation and XBP1 splicing in alcohol-fed mice
and observed that alcohol consumption slightly decreased
IRE1 phosphorylation (Figure 4C). In addition, we observeda lack of spliced XBP1 (Figure 4D), and, consequently, no
induction of XBP1 protein in the majority of livers of
alcohol-fed mice (Figure 4E). Interestingly, the unspliced
XBP1u (w26 kilodaltons) was increased slightly in alcohol-
fed mice at the mRNA and protein level; the relevance of this
ﬁnding remains to be clariﬁed. These data show that alcohol
feeding induced ER stress and activated ATF6, but failed to
splice XBP1, and, consequently, did not up-regulate ER
chaperones.
Acrolein Adduct Accumulation and ER Stress
Occur Concurrently With Proapoptotic Signaling
Uncontrolled ER stress in cells can result in apoptosis,
which is thought to occur by various proapoptotic path-
ways.25 Accordingly, we examined the effects of alcohol
consumption on relevant ER-associated apoptotic signaling
in alcohol-fed mice. The activation of IRE1 leads to its
interaction with TRAF2 and ASK1, and subsequent activa-
tion of mitogen/stress kinase, JNK, which is connected to ER
stress-induced apoptosis. The sustained activation of JNK by
phosphorylation is implicated in hepatocyte apoptosis and
several forms of liver injury.26 Hepatocytes express both
isozymes JNK1 (46 kilodaltons) and JNK2 (54 kilodaltons),
which regulate inﬂammation, cell proliferation, and death in
a cell type–dependent and contextual manner. Our data
show that alcohol consumption caused signiﬁcant phospho-
activation of both JNK1 and JNK2, whereas total JNK was
reduced very slightly compared with control mice
(Figure 5A).
Another relevant ER-driven apoptotic pathway involves
the proteolytic activation of the ER-resident caspase-12,
which is known to subsequently activate caspase-9 and
caspase-3, resulting in apoptotic cell death.27 Correspondent
to ER stress, alcohol consumption also caused proteolytic
activation of caspase-12, as shown by a decrease in pro-
caspase-12 (w55 kilodaltons) and a concurrent increase
in the cleaved form (w38 kilodaltons) (Figure 5B). The
third and possibly the most well-characterized pathway of
ER stress-induced apoptosis is via up-regulation of CHOP,
which primarily is responsible for ER stress-induced cell
death.4,28 Activated CHOP leads to alterations in Bcl2 and
BAX, in turn, leading to activation of the mitochondrial death
pathway, which is known to be involved in alcohol-induced
liver injury. The CHOP gene promoter contains binding sites
for transcription factors ATF4 and ATF6, which both are
activated by alcohol (Figures 3 and 4, respectively). Corre-
spondingly, alcohol consumption resulted in an approxi-
mately 5-fold up-regulation of CHOP mRNA (Figure 5C); and
a concomitant increase in CHOP protein (Figure 5D). Thus,
alcohol consumption and consequent acrolein build-up
in mice activates ER-associated proapoptotic signaling
pathways.
Hepatic Acrolein Accumulation and ER Stress
Are Accompanied by Steatosis, Hepatocyte
Apoptosis, and Liver Injury
In keeping with literature showing that hepatic ER stress
is linked causally to steatosis,29 we examined the effects on
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lein and ER stress, we observed substantial microvesicular
and macrovesicular hepatic steatosis in alcohol-exposed
mice compared with controls, as seen by lipid droplet
accumulation by H&E and Oil Red O staining (Figure 6A).
Furthermore, the activation of proapoptotic signaling
culminated in apoptotic cell death in the livers of alcohol-fed
mice, as seen by a signiﬁcant increase in TUNEL-positive
staining in the livers of alcohol-fed mice compared with
control (Figure 6B), which led to greater liver injury as
deﬁned by serum ALT and AST levels (Figure 6C). Thus,
concomitant with alcohol-induced accumulation of acrolein
and ER stress, an increase was observed in hepatic steatosis
and hepatocyte apoptosis, leading to liver injury in alcohol-
fed mice.
Acrolein Mimics the In Vivo Effects of Alcohol in
Cultured Hepatic Cells
Along with acrolein, alcohol metabolism in the liver is
capable of giving rise to many toxic metabolites including 4-
Hydroxynonenal and malondialdehyde. Hence, to isolate and
determine the sole contribution of acrolein in alcohol-
induced hepatic injury, we used H4IIEC cells to examine
the direct in vitro effects of acrolein in comparison with
alcohol, particularly pertaining to induction of ER stress and
hepatocyte cell death. Similar to alcohol exposure, direct
acrolein exposure of H4IIEC cells resulted in considerable
acrolein adduct accumulation (Figure 7A). Furthermore,
analogous to alcohol exposure, direct in vitro acrolein
exposure of hepatocytes resulted in ER stress and cell death.
We exposed H4IIEC cells to different concentrations of
either alcohol (50, 100, or 200 mmol/L) or acrolein (20 or
30 mmol/L) for 6 hours (for mRNA) or 24 hours (for pro-
tein). These concentrations of alcohol represent levels that
may be encountered with moderate to high alcohol con-
sumption. The exact levels of acrolein that may be generated
in the liver after alcohol consumption are difﬁcult to predict,
and the acrolein concentrations used here are based on
published studies and represent pathophysiological levels
that caused hepatocyte apoptosis. Exposure of H4IIEC cells
to either acrolein or alcohol yielded similar results: both
triggered ER stress and increased ATF3 and ATF4, with
minimal up-regulation of GRP78 and GRP94, but a robust
increase in proapoptotic CHOP (Figure 7B [mRNA] and C
[protein]). Furthermore, consistent with the induction of
CHOP, we observed a corresponding loss of cell survivalFigure 4. Alcohol-induced accumulation of acrolein
adducts does not induce UPR adaptive responses in mice
livers. (A) GRP78andGRP94mRNA levels.Means±SEM,n¼ 6
mice. *P < .05 and **P < .01 compared with control by the
Student t test. (B) GRP78 and GRP94 protein levels. (C) Protein
levels of ATF6andcleaved/activeATF6, phospho-IRE1, and total
IRE1. (D) XBP1 splicing by semiquantitative end point reverse-
transcription polymerase chain reaction visualized by agarose
gel electrophoresis. (E) Protein levels of XBP1s and XBP1u. (B,C,
and E) Numbers represent mean densitometry ratios normalized
to corresponding control proteins (b-actin or total IRE1). C, con-
trol; E, alcohol.
Figure 5. Alcohol-induced hepatic acrolein build-up and consequent ER stress leads to proapoptotic signaling in mice
livers. (A) Phospho-JNK and total JNK protein levels. (B) Pro- and cleaved/active caspase-12 protein levels. (C) CHOP mRNA
levels. Means ± SEM, n ¼ 6 mice. **P < .01 compared with control by the Student t test. (D) CHOP protein levels. (A, B, and D)
Numbers represent mean densitometry ratios normalized to corresponding control proteins (total JNK or b-actin). C, control; E,
alcohol.
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the effects of alcohol in cultured hepatic cells, indicating that
the adverse effects of alcohol may indeed be attributed to
increased acrolein in the liver occurring as a result of
alcohol consumption.Acrolein Scavengers Showed Protective Effects
Both In Vitro and In Vivo
To conﬁrm the contribution of acrolein and establish its
pathogenic role in alcohol-induced ER stress and liver
injury, we tested known acrolein scavengers in mitigating
the injurious effects of acrolein build-up. In this study, we
used a known acrolein scavenger, hydralazine, which is
known to neutralize free acrolein30,31 and acrolein-protein
adducts,32,33 both of which are cytotoxic. Also, hydralazine
was shown effectively to prevent acrolein-mediated cell
death and tissue damage in spinal cord injury.10,34 In
addition, we also used carnosine (b-alanyl histidine, an
endogenous dipeptide) that is known to scavenge aldehydes
such as acrolein, and have beneﬁcial effects against
acetaminophen-induced liver injury.35 H4IIEC cells were
pretreated with 50 mmol/L hydralazine or 100 mmol/L
carnosine for 1 hour before alcohol or acrolein exposure,
and the effect on cell viability was monitored by the 3, (4,
5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide
assay. Acrolein- or alcohol-induced cell death was attenu-
ated signiﬁcantly by both acrolein scavengers, and hydral-
azine was slightly more effective (Figure 8A).Finally, to ﬁrmly establish the role of acrolein in the
development of ALD in vivo, we also tested the efﬁcacy of
hydralazine in scavenging acrolein and protecting against
alcohol-induced liver injury in the NIAAA murine model of
ALD. Hydralazine (5 mg/kg body weight, dose based on pre-
vious literature31,34) was administered by daily intraperito-
neal injection along with the 10-day alcohol feeding regimen.
As noted previously, consumption of the alcohol diet resulted
in signiﬁcant hepatic acrolein adduct accumulation and
steatosis in the liver, and the acrolein scavenger hydralazine
effectively blocked alcohol-induced acrolein formation and
adduct accumulation (Figure 8B) and dramatically reduced
hepatic steatosis as seen by histologic examination and
conﬁrmed by Oil Red O staining (Figure 8B). Furthermore,
alcohol-induced hepatic ER stress and transcriptional up-
regulation of hallmark ER stress mRNAs (ATF3, ATF4,
CHOP, and GRP78) also were attenuated substantially by
hydralazine to control levels (Figure 8C). Importantly, hy-
dralazine prevented alcohol-induced proapoptotic signaling
and activation of JNK, pro-caspase-12, and CHOP (Figure 8D).
A corresponding decrease was seen in alcohol-induced he-
patic apoptosis as seen by decreased TUNEL-positive cells
(Figure 8E). Finally, hydralazine showed dramatic protective
effects against alcohol-induced liver injury with signiﬁcantly
reduced serum ALT and AST levels (Figure 8F). These data
show that hydralazine administration, which targeted
alcohol-induced hepatic acrolein via sequestration/neutrali-
zation, signiﬁcantly attenuated ER stress, apoptosis, and liver
injury, and protected against ALD in mice (Figure 9).
Figure 6. Alcohol-induced
acrolein and ER stress
leads to steatosis, hepa-
tocyte apoptosis, and
liver injury in mice livers.
(A) Hepatic steatosis
(by H&E; magniﬁcation,
40) and Oil Red O stain-
ing; magniﬁcation, 20). (B)
Apoptosis by TUNEL
staining (magniﬁcation,
20), with quantiﬁcation of
apoptosis. Means ± SEM,
n ¼ 6 mice. ***P < .001
compared with control by
Student t test. (C) Liver
injury: serum ALT and AST.
Means ± SEM, n ¼ 6 mice.
**P < .01 and ***P < .001
compared with control by
the Student t test. C, con-
trol; E, alcohol.
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Figure 7. Acrolein mimics the in vivo effects of alcohol and causes ER stress and cell death in cultured hepatic cells. (A)
Accumulation and quantiﬁcation of acrolein adducts (immunocytochemistry using speciﬁc FDP-lysine antibodies; magniﬁ-
cation, 20) in H4IIEC cells treated for 24 hours. Means ± SEM, n ¼ 4. **P < .01 and ***P < .001 compared with control by
analysis of variance–Bonferroni analysis. (B) ATF3, ATF4, GRP78, GRP94, and CHOP mRNA levels at 6 hours. Means ± SEM,
n ¼ 3 experiments. *P < .05 and **P < .01 compared with control by analysis of variance–Bonferroni analysis. (C) ATF3, ATF4,
GRP78, GRP94, and CHOP protein levels from untreated cells (C) or cells treated for 24 hours with alcohol at 50 mmol/L (E50),
100 mmol/L (E100), 200 mmol/L (E200), or acrolein at 20 mmol/L (A20) or 30 mmol/L (A30). Immunoblot analysis was repeated 3
times with similar results, and representative blots are shown. Numbers denote densitometry ratios normalized to corre-
sponding b-actin levels. (D) Cell survival by 3, (4, 5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide assay (24 h). Means
± SEM, n ¼ 3 experiments. *P < .05 compared with control by analysis of variance–Bonferroni analysis. C, control; E, 200
mmol/L alcohol; and A, 30 mmol/L acrolein.
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Alcohol consumption is a major health problem world-
wide and in the United States, with no Food and Drug
Administration–approved therapy for any stage of ALD.
Therefore, it is critical to investigate the mechanisms
involved in ALD, and to identify novel therapeutic targets
and strategies for the prevention and treatment of ALD. In
this study, we pursued in vitro and in vivo studies to show
the role of the lipid peroxidation by-product, acrolein, in
contributing to alcohol-induced hepatic ER stress, steatosis,
cell death and liver injury, and the pathogenesis of ALD. Our
study shows the following: (1) alcohol consumption gener-
ates hepatic acrolein, triggers pathologic ER stress and
hepatocyte apoptosis, with insufﬁcient activation of
ER-adaptive/protective responses; (2) alcohol-inducedacrolein is a major mediator of hepatic ER stress, cell
death and injury, and is a potential therapeutic target in
ALD; and (3) removal/clearance of acrolein by scavengers
has therapeutic potential in ALD (Figure 9).
Our results showed signiﬁcant generation/accumulation
of acrolein in the liver after alcohol exposure resulting in
cytoplasmic and nuclear accumulation of acrolein-adducted
proteins. The accumulation of acrolein–protein adducts
triggered consequent hepatic ER stress, leading to hepato-
cyte cell death and liver injury. Notably, all 3 ER stress
pathways involving the ER sensors PERK, IRE1, and ATF6
were activated; however, not all ER stress genes were
affected in the same way. Alcohol consumption appeared to
trigger ER stress and induced apoptotic signaling (JNK,
caspase-12, and CHOP), while simultaneously suppressing
Figure 8. Acrolein scavengers show protective effects both in vitro and in vivo. (A) Cell survival in H4IIEC cells by 3, (4, 5-
dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide assay (24 h). Means ± SEM, n ¼ 3 experiments. *P < .05 compared with
the corresponding treatments of alcohol (E) or acrolein (A) alone, by analysis of variance–Bonferroni analysis. C, control; E, 200
mmol/L alcohol; A, 30 mmol/L acrolein; HYD, 50 mmol/L hydralazine; CAR, 100 mmol/L carnosine. (B–F) Data are from livers of
mice. E, alcohol; HydþE, hydralazineþalcohol. (B) Hepatic acrolein adduct accumulation in mice (magniﬁcation, 20), hepatic
steatosis by H&E (magniﬁcation, 80), and Oil Red O staining (magniﬁcation, 20). (C) ATF3, ATF4, GRP78, GRP94, and
CHOP mRNA levels. Data are presented as means ± SEM (n ¼ 6 mice). *P < .05 and ***P < .001 compared with alcohol (E) by
analysis of variance–Bonferroni analysis. (D) Protein levels of phospho-JNK and total JNK, pro- and cleaved/active caspase
12, and CHOP. Numbers represent mean densitometry ratios normalized to corresponding control proteins (total JNK or
b-actin). (E) Apoptosis by TUNEL staining (magniﬁcation, 80), with quantiﬁcation of apoptosis. **P < .01 compared with E by
analysis of variance–Bonferroni analysis. (F) Liver injury: serum ALT and AST. Means ± SEM, n ¼ 6 mice. **P < .01 and ***P <
.001 by analysis of variance–Bonferroni analysis.
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ones (GRP78 and 94). The differential regulation of ER
stress genes may be via altered signal transduction, or by
direct or indirect protein adduction. In addition, the nuclear
accumulation of acrolein adducts may indicate adduction
and alteration of function of transcription factors or
chromatin-modifying proteins such as histone deacetylases
and DNA/histone methylases, which likely have signiﬁcant
effects on downstream gene expression. The exact mecha-
nisms by which acrolein adduct accumulation causes ER
stress, and the identity and functionality of the proteins
adducted by acrolein, currently are under investigation.
Oxidative stress is known to induce ER stress, however,
the mediators responsible for such effects have not been
identiﬁed clearly. Alcohol-induced oxidative stress and
aldehyde generation is shown to occur in the absence of ER
stress in a model of early ALD, suggesting that ER stress
may be a downstream consequence of oxidant burden.36
Our data clearly show a direct mechanistic link and iden-
tify acrolein as a major pathogenic initiator of alcohol-
induced hepatic injury. The causal role of acrolein in the
pathogenesis of ALD is supported further by the observation
that clearance of this toxic molecule by hydralazine (aknown acrolein scavenger) largely prevented alcohol-
induced acrolein build-up, and ER stress, cell death, and
injury. With regard to acrolein generation during the
development of ALD, our novel results show that alcohol-
mediated down-regulation of GSTP may be a key mecha-
nism that reduces the normal metabolism/clearance of
acrolein, thereby contributing to hepatic accumulation of
acrolein and consequent liver injury. Indeed, GSTP may be a
potential therapeutic target, and pharmacologic activation of
GSTP may be of beneﬁt to attenuate ALD. In addition, our
data indicate that alcohol metabolism is essential, and that
both ADH- and CYP2E1-dependent pathways contribute to
acrolein generation/accumulation. Importantly, our data
show that acetaldehyde, the ﬁrst metabolite of alcohol, plays
a key role in alcohol-induced acrolein formation because
direct exposure to acetaldehyde resulted in substantial
acrolein accumulation in H4IIEC cells. Moreover, acetalde-
hyde may further support acrolein formation via up-
regulation of spermine oxidase, which catalyzes the
formation of free acrolein by oxidation of spermine as
reported by Uemura et al.37 The vital role of ALDH2
in detoxiﬁcation of aldehydes (both acetaldehyde and
acrolein) was shown clearly by the observation that
Figure 8. (continued).
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Figure 9. Acrolein mediates alcohol-induced hepatic ER
stress, apoptosis, and injury in ALD, and the scavenger,
hydralazine, prevents these effects.
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(ALDH2 agonist) prevented alcohol-induced acrolein accu-
mulation in cultured hepatocytes; these data are in keeping
with the recent demonstration that (N-(1,3-Benzodioxol-5-
ylmethyl)-2,6-dichlorobenzamide) protects against alcohol-
induced steatosis and cell death.38
Our data show that alcohol consumption causes patho-
logic ER stress without sufﬁcient induction of the adaptive/
protective responses involving XBP1s splicing and up-
regulation of ER chaperones. Thus, insufﬁcient adaptation
to ER stress along with proapoptotic signaling may
contribute signiﬁcantly to hepatic injury in this model of
alcohol consumption. Although XBP1 splicing occurred in a
few alcohol-fed mice, GRP78 or GRP94 were not up-
regulated signiﬁcantly, suggesting that additional factors
(such as other proteins or epigenetic modiﬁcations) also
may be involved. A similar discordant lack of correlation
between chaperone gene expression and upstream signal
transduction (cleavage of ATF6 and splicing of XBP1)39 has
been reported in dermal ﬁbroblasts. Our data in the chronic
binge murine model showing minimal to no increase in
chaperones GRP78 and GRP94 differs from the murine
intragastric alcohol feeding model, which showed substan-
tial up-regulation of GRP78, along with CHOP and hepatic
steatosis and injury.40 In addition, in guinea-pigs fed alcohol,
liver steatosis and apoptosis were accompanied by
increased mRNA and protein levels of CYP2E1 and GRP78,
and activated caspase-12.41 These variations in ER stress-
associated gene expression may reﬂect differences in
model systems pertaining to animals, routes of alcohol
feeding, or temporal patterns of gene expression. Our study
emphasizes the important role of pathologic ER stress in
alcohol-induced liver injury in this model of ALD, and in-
dicates that impaired ER adaptive responses (eg, GRP78)
may contribute signiﬁcantly to injury in ALD, as has beendescribed in other forms of liver injury.42 ER stress is
known to result in JNK activation through the IRE1-TRAF
pathway; however, several other stimuli also activate JNK,
including TNF and TRAIL, both of which are known to be
increased in alcohol-fed mice. The direct causative role of
ER stress in JNK activation and alcohol-induced injury
clearly is suggested, but was not established, by our work.
Future studies to conﬁrm this concept will involve investi-
gating the effects of pharmacologic or genetic inhibition of
ER stress on JNK activation, apoptosis, and liver injury.
Notably, in addition to showing the pathogenic contri-
bution of acrolein in the development of experimental ALD,
our study also provides novel and exciting evidence that
acrolein removal or scavenging using hydralazine is an
effective way to mitigate alcohol-induced hepatic ER stress,
steatosis, and injury in experimental ALD, both in vitro and
in vivo. Although the protective effects of hydralazine are
reported primarily against acrolein,33 it is possible that
hydralazine also may interact with and neutralize other
toxic aldehydes such as 4-Hydroxynonenal, thereby
providing added protection in ALD. In our study, hydral-
azine prevented liver injury when administered from the
start of alcohol feeding; additional studies are needed to test
its efﬁcacy in a treatment paradigm. Although the data
convincingly show that acrolein removal/clearance by hy-
dralazine may be a novel and effective treatment modality,
the use of hydralazine in the treatment of ALD patients may
be somewhat limited because hydralazine has vasodilator
properties. Alternative compounds, with the same
hydrazine-based acrolein scavenging mechanism but
without the vasodilator effects, such as dihydralazine and
the antidepressant phenelzine,43 may need to be investi-
gated for safety and efﬁcacy in ALD. Further studies are
needed to understand the exact mechanism by which
alcohol-induced acrolein leads to ER stress, and to examine
the contribution of acrolein in alcohol-induced hepatic
inﬂammation. In addition to hepatic effects, alcohol-induced
intestinal permeability and consequent systemic endotox-
emia are known to be important in the pathogenesis of ALD;
the possible involvement of acrolein in alcohol-induced in-
testinal dysfunction remains to be explored. These detailed
mechanistic studies currently are under investigation in our
laboratory.Clinical Relevance
Only approximately 30% of heavy alcohol drinkers
develop severe ALD, and dietary and environmental factors
are thought to be critical determinants. Acrolein is a common
environmental and dietary pollutant and our study shows
that it is a major mediator of the adverse effects of alcohol
and plays a causal role in experimental ALD pathogenesis.
Our group has shown that diets enriched in linoleic acid
(common dietary PUFA) exacerbate alcohol-induced liver
injury,44 and consumption of linoleic acid has increasedmore
than 3-fold over the past 2 decades, thereby increasing the
substrate availability for LPO and subsequent acrolein gen-
eration. In addition, acrolein is a major aldehyde component
of cigarette smoke45 and cigarette smoking is common in
September 2016 Hydralazine Prevents Acrolein-Mediated ALD 699persons consuming alcohol and is known to impact alcoholic
liver disease negatively. Thus, environmental and dietary
acrolein exposures may add to endogenously generated
acrolein with signiﬁcant and clinically relevant pathogenic
consequences. Our results indicate that acrolein is a major
pathogenic contributor and may be an important therapeutic
target in ALD. Notably, our study shows that acrolein
neutralization/clearance may be an effective strategy for
curtailing alcohol-induced, acrolein-mediated hepatic injury
in the development of ALD. Hence, acrolein scavengers such
as hydralazine may represent a novel therapeutic approach
for the prevention/treatment of ALD.References
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